Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 May-Jun;25(3A):1703-5.

Pleomorphic adenoma of the salivary glands: analysis of 94 patients

Affiliations
  • PMID: 16033086
Free article

Pleomorphic adenoma of the salivary glands: analysis of 94 patients

Reinhard E Friedrich et al. Anticancer Res. 2005 May-Jun.
Free article

Abstract

Pleomorphic adenoma is a benign epithelial tumor of adenoid structure preferentially arising from the parotid gland. It was shown that complete tumor excision is a curative measure and recurrence is likely in incompletely excised tumors. The aim of this study was to analyse the outcome of patients with pleomorphic adenoma from salivary glands in order to evaluate the surgical strategy of a single institution.

Materials and methods: The files of 94 patients were evaluated. Special attention was given to the development of malignancy in pleomorphic adenoma.

Results: The pleomorphic adenoma preferentially originated in the parotid gland (n=73; right 48, left: 25), and rarely in other glands. The tumor occurred more often in females than in males (45:28, parotid). In 73 patients a slowly growing swelling of the parotid was first noted, which was located at different sites within the gland. At least one recurrence was noted in 18 patients, the majority of them aged 50 to 70 years (n=12). Malignant transformation to carcinoma was found in 8.5%.

Conclusion: Pleomorphic adenoma from salivary glands is a benign tumor. However, in a noteworthy number of patients, inside the benign tumor a phenotype develops with distinct properties of malignancy. Surgery with safety margins is the therapy of choice. Multinodular tumors are prone to recurrent disease.

PubMed Disclaimer

LinkOut - more resources